| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |